Marshall Wace North America’s Select Medical SEM Stock Holding History

Marshall Wace North America’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-186,253	Closed	-$4.24M	–	1684
2021 Q2	$4.24M	Sell	186,253 -342,753	-65%	-$7.11M	0.02%	598
2021 Q1	$9.72M	Buy	+529,006	New	+$8.67M	0.04%	402
2020 Q4	–	Sell	-97,538	Closed	-$1.09M	–	1552
2020 Q3	$1.09M	Buy	+97,538	New	+$960K	0.01%	778
2019 Q3	–	Sell	-108,856	Closed	-$931K	–	1522
2019 Q2	$931K	Sell	108,856 -24,225	-18%	-$191K	0.01%	774
2019 Q1	$1.01M	Sell	133,081 -58,553	-31%	-$471K	0.01%	662
2018 Q4	$1.58M	Buy	+191,634	New	+$1.83M	0.02%	490
2018 Q3	–	Sell	-446,557	Closed	-$4.37M	–	1321
2018 Q2	$4.37M	Sell	446,557 -783,147	-64%	-$7.69M	0.02%	547
2018 Q1	$11.4M	Buy	1,229,704 +114,229	+10%	+$1.09M	0.06%	370
2017 Q4	$10.6M	Buy	1,115,475 +1,007,081	+929%	+$9.62M	0.06%	372
2017 Q3	$1.11M	Buy	+108,394	New	+$1M	0.01%	923
2013 Q4	$444K	Buy	+70,988	New	+$347K	0.01%	543

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Marshall Wace North America's SEM Position: Q3 2021 in Review

Marshall Wace North America sold out of Select Medical (SEM) in Q3 2021, closing a stake of 186,253 shares — an estimated $4.24M sold.

Marshall Wace North America first reported a position in SEM in Q4 2013 and held it in 11 quarters. The position peaked at $11.4M in Q1 2018. 252 funds tracked by Wall St. Rank hold SEM as of Q3 2021.

Marshall Wace North America reported no remaining Select Medical position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 186,253 Select Medical shares in Q3 2021, an estimated $4.24M.
Marshall Wace North America first reported a position in Select Medical in Q4 2013 and held it in 11 quarters.
Marshall Wace North America's Select Medical position peaked at $11.4M in Q1 2018.
252 funds tracked by Wall St. Rank held Select Medical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.